Announcing the Global and National Laureate Awards 2026: Honoring innovators in 20 distinct Nanotechnology disciplines! X
or
Login with Google

Missax Bad Medicine [better] -

| Parameter | Assessment | |-----------|------------| | | Limited and low‑quality evidence; modest symptomatic relief for allergic rhinitis only. | | Safety | Multiple serious organ toxicities; high signal for liver and cardiac events. | | Alternatives | Numerous FDA‑approved antihistamines (e.g., cetirizine, fexofenadine) and leukotriene modifiers with robust safety records. | | Overall | Negative – The marginal benefit does not outweigh the documented risks. The drug’s risk profile is unacceptable for routine clinical use. |

💬 If you’re looking for a tune that’s both a cure and a curse, press play. Just don’t blame us if you can’t shake it off later. 🎧 missax bad medicine

InstaNANO AI Assistant
Online